0 Comentários
0 Compartilhamentos
434 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Generic Oncology Drugs Market to See Consistent Growth Through 2036 Amid Rising Focus on Expanding Cancer Care AccessNEWARK, Del., July 17, 2026 — The Generic Oncology Drugs Market is expected to witness steady growth as healthcare systems worldwide increasingly prioritize affordable cancer treatment and broader patient access to life-saving therapies. According to Future Market Insights (FMI), the market is projected to grow from USD 24.4 billion in 2026 to USD 31.5 billion by 2036, registering a 2.6%...0 Comentários 0 Compartilhamentos 355 Visualizações 0 Anterior
-
Generic Oncology Drugs Market to See Consistent Growth Through 2036 Amid Rising Focus on Expanding Cancer Care AccessNEWARK, Del., July 17, 2026 — The Generic Oncology Drugs Market is expected to witness steady growth as healthcare systems worldwide increasingly prioritize affordable cancer treatment and broader patient access to life-saving therapies. According to Future Market Insights (FMI), the market is projected to grow from USD 24.4 billion in 2026 to USD 31.5 billion by 2036, registering a 2.6%...0 Comentários 0 Compartilhamentos 423 Visualizações 0 Anterior
-
Intravesical Bacillus Calmette Market Trends in Oncology and Urology CareThe global intravesical Bacillus Calmette market is experiencing significant growth due to the increasing prevalence of bladder cancer and the rising adoption of immunotherapy-based treatment approaches. Intravesical Bacillus Calmette therapy has become one of the most widely used treatment options for non-muscle invasive bladder cancer (NMIBC), offering effective recurrence prevention and...0 Comentários 0 Compartilhamentos 847 Visualizações 0 Anterior
-
North America Somatostatin Market Outlook: Expanding Applications in Endocrinology and Oncology CareThe North American Somatostatin Market continues to hold a dominant position in the global healthcare landscape, supported by advanced healthcare infrastructure, strong pharmaceutical research capabilities, and increasing adoption of targeted therapies for endocrine and neuroendocrine disorders. The region benefits from a high prevalence of conditions such as acromegaly, neuroendocrine tumors...0 Comentários 0 Compartilhamentos 334 Visualizações 0 Anterior
-
Oncology Day-Care Treatment Services Market Analysis, Revenue & Future Growth Outlook"Oncology Day-Care Treatment Services Market Summary According to the latest report published by Data Bridge Market Research, the Oncology Day-Care Treatment Services Market The global Oncology Day-Care Treatment Services market was valued at USD 3.94 billion in 2025 and is projected to reach USD 11.23 billion by 2033, growing at a CAGR of 14.00% from 2026 to...0 Comentários 0 Compartilhamentos 45 Visualizações 0 Anterior
-
Oncology Supportive Care Innovations Accelerate Chemotherapy Induced Neutropenia Treatment MarketThe global Chemotherapy Induced Neutropenia (CIN) Treatment Market is experiencing sustained growth as healthcare providers increasingly focus on minimizing chemotherapy-related complications and improving patient outcomes. According to Polaris Market Research, the market was valued at USD 597.23 Million in 2024 and is expected to reach USD 775.84 Million by 2034, registering a CAGR of 3.30%...0 Comentários 0 Compartilhamentos 419 Visualizações 0 Anterior
-
Oral Mucositis Drugs Market Advances with Novel Supportive Care Therapies and Growing Oncology Treatment DemandAccording to the latest report published by Data Bridge Market Research, the Oral Mucositis Drugs Market Data Bridge Market Research analyses that the global oral mucositis drugs market which was USD 530.00 million in 2023, would rocket up to USD 896.62 million by 2030, and is expected to undergo a CAGR of 7.80% during the forecast period. This Oral Mucositis Drugs Market research...0 Comentários 0 Compartilhamentos 693 Visualizações 0 Anterior
-
The Growing Role of Supportive Oncology Care in the Chemotherapy Induced Peripheral Neuropathy MarketChemotherapy-Induced Peripheral Neuropathy (CIPN) is one of the most common and challenging side effects associated with cancer therapy, affecting patients' quality of life and treatment outcomes. According to market estimates, the chemotherapy induced peripheral neuropathy market is expected to grow from US$ 1.01 billion in 2025 to US$ 1.67 billion by 2034, registering a CAGR of 5.71% during...0 Comentários 0 Compartilhamentos 371 Visualizações 0 Anterior
-
Thymus (T)-Cell Lymphoma Treatment Market Advances with Novel Immunotherapies and Targeted Oncology Innovations Enhancing Patient CareAccording to the latest report published by Data Bridge Market Research, the Thymus (T)-Cell Lymphoma Treatment Market The global thymus (T)-cell lymphoma treatment market size was valued at USD 1.85 billion in 2025 and is expected to reach USD 3.69 billion by 2033, at a CAGR of 9.02% during the forecast period An influential Thymus (T)-Cell Lymphoma Treatment Market document...0 Comentários 0 Compartilhamentos 490 Visualizações 0 Anterior
-
U.S. AI in Oncology Market: Rising Adoption of AI Technologies Driving the Future of Cancer CareThe U.S. AI in Oncology Market is witnessing remarkable growth as artificial intelligence (AI) becomes increasingly integrated into cancer diagnosis, treatment planning, drug discovery, and patient management. Healthcare providers, research institutions, pharmaceutical companies, and technology developers are leveraging AI-powered solutions to improve clinical decision-making, enhance...0 Comentários 0 Compartilhamentos 317 Visualizações 0 Anterior
-
U.S. Lung Cancer Surgery Market Strengthened by Expanding Oncology Care InfrastructureThe United States represents the largest contributor to the Lung Cancer Surgery Market, supported by a well-established healthcare infrastructure, high adoption of advanced surgical technologies, and significant investments in cancer treatment. The country continues to witness strong demand for lung cancer surgeries due to the high prevalence of lung cancer and increasing emphasis on early...0 Comentários 0 Compartilhamentos 254 Visualizações 0 Anterior
-
All Trans Retinoic Acid Market to Reach USD 780 Million by 2034 | CAGR 4.7%According to a newly published market research report by 24LifeSciences, global all trans retinoic acid market was valued at USD 520 million in 2025 and is projected to reach USD 780 million by 2034, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034. All Trans Retinoic Acid (ATRA), chemically known as tretinoin, is a derivative of vitamin A...0 Comentários 0 Compartilhamentos 4K Visualizações 0 Anterior
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 Comentários 0 Compartilhamentos 5K Visualizações 0 Anterior
-
Chromatography Instrumentation Market Scope and Growth Analysis by 2034The Chromatography instrumentation has become an essential component in modern analytical science, enabling precise separation, identification, and quantification of chemical compounds across multiple industries. Its application spans pharmaceuticals, biotechnology, environmental monitoring, and food safety testing, where accuracy and compliance are critical. The increasing complexity of...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior1
-
GVHD Treatment Market to Reach USD 2.1 Billion by 2031 | CAGR 8.5%According to a newly published market research report by 24LifeSciences, global Graft Versus Host Disease (GVHD) Treatment market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 20252031. Graft versus Host Disease, a serious complication following stem cell or bone...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Interventional Oncology Market Growth Supported by Healthcare InvestmentsThe interventional oncology market is experiencing significant growth as healthcare providers increasingly adopt minimally invasive procedures for cancer diagnosis and treatment. The global interventional oncology market size was valued at USD 2.9 billion in 2025 and is projected to grow from USD 3.2 billion in 2026 to USD 5.6 billion by 2033, at a CAGR of 8.6% from 2026 to 2033. The market in...0 Comentários 0 Compartilhamentos 86 Visualizações 0 Anterior
Páginas Impulsionadas